A continuous flow synthesis and derivatisation of 1,2,4-thiadiazoles. by Baumann,  M. & Baxendale,  I. R.
Durham Research Online
Deposited in DRO:
25 January 2017
Version of attached ﬁle:
Accepted Version
Peer-review status of attached ﬁle:
Peer-reviewed
Citation for published item:
Baumann, M. and Baxendale, I. R. (2017) 'A continuous ﬂow synthesis and derivatisation of
1,2,4-thiadiazoles.', Bioorganic and medicinal chemistry., 25 (23). pp. 6218-6223.
Further information on publisher's website:
https://doi.org/10.1016/j.bmc.2017.01.022
Publisher's copyright statement:
c© 2017 This manuscript version is made available under the CC-BY-NC-ND 4.0 license
http://creativecommons.org/licenses/by-nc-nd/4.0/
Additional information:
Use policy
The full-text may be used and/or reproduced, and given to third parties in any format or medium, without prior permission or charge, for
personal research or study, educational, or not-for-proﬁt purposes provided that:
• a full bibliographic reference is made to the original source
• a link is made to the metadata record in DRO
• the full-text is not changed in any way
The full-text must not be sold in any format or medium without the formal permission of the copyright holders.
Please consult the full DRO policy for further details.
Durham University Library, Stockton Road, Durham DH1 3LY, United Kingdom
Tel : +44 (0)191 334 3042 | Fax : +44 (0)191 334 2971
http://dro.dur.ac.uk
Graphical Abstract 
To create your abstract, type over the instructions in the template box below. 
Fonts or abstract dimensions should not be changed or altered. 
A Continuous Flow Synthesis and 
Derivatisation of 1,2,4-Thiadiazoles 
Marcus Baumann and Ian R. Baxendale 
Department of Chemistry, University of Durham, South Road, DH1 3LE. Durham, United Kingdom. 
 
Leave this area blank for abstract info. 
  
Bioorganic & Medicinal Chemistry 
journal  homepage:  www.e lsevier .com  
 
A Continuous Flow Synthesis and Derivatization of 1,2,4-Thiadiazoles 
Marcus Baumann
a,  and Ian R. Baxendalea 
aDepartment of Chemistry, University of Durham, South Road, DH1 3LE. Durham, United Kingdom. 
 
——— 
 Corresponding author. Tel.: +0-000-000-0000; fax: +0-000-000-0000; e-mail: author@university.edu 
1. Introduction 
Thiadiazoles represent a unique subclass of bioactive five-
membered aromatic heterocycles containing one sulfur and two 
nitrogen atoms.
1-4
 The presence of these heteroatoms increases 
both the membrane permeability as well as the ability to act as 
versatile hydrogen bond acceptors. Due to the spacial similarity 
of vinyl groups to ring embedded sulfur atoms thiadiazoles can 
be considered isosteres of diazines
5,6 
adding to their potential to 
serve as fragments of bioactive structures.
7-10
 Thiadiazoles can 
occur in four distinct regioisomeric forms (1-4) enriching their 
structural diversity with respect to local polarization and vector 
space occupied by both carbon bound substituents R1 and R2 
(Figure 1).  
 
Figure 1: Regioisomerism of thiadiazoles (1-4). 
Amongst the possible thiadiazole isoforms the 1,2,4-
thiadiazole scaffold is an important structure as it resembles the 
ubiquitous pyrimidine moiety. The synthesis of 1,2,4-thiadiazoles 
can be accomplished by a variety of methods including oxidative 
ring closure,
11,12
 multicomponent reactions
13
 or [3+2]-
cycloadditions.
14
 A further option which is more amenable to 
subsequent functionalization on the heterocyclic scaffold  is 
based on reacting various amidines with trichloromethane 
sulfenylchloride (5, Scheme 1).
15
 Although very versatile this 
reagent poses several safety risks as it is unstable and readily 
decomposes into highly corrosive and malodorous species.
16
 In 
order to mitigate these hazards we decided to harness the benefits 
of flow reactor technology
17-26
 to study the safe and efficient use 
of trichloromethane sulfenylchloride en route to 5-chloro-1,2,4-
thiadiazoles that would allow further functionalization reactions 
to take place at the activated 5-position of this scaffold.  
2. Results and Discussion 
In order to safely employ trichloromethane sulfenylchloride 
we opted to utilize a Vapourtec R-series flow system
27
 as it is 
amenable to using either the injection sample loops (for small 
scale reactions) or pumping directly from reagent bottles (for 
scale up operations).  
Scheme 1: Flow reactor set-up. 
Stock solutions of trichloromethane sulfenylchloride (5, 0.45 
M in EtOAc) and hydrated benzamidine hydrochloride salt (6, 
0.4 M in 1.5 M aqueous NaOH) were freshly prepared before 
each set of experiments and used up within 2-3 h. As depicted in 
Scheme 1 the reagent solutions were loaded into the sample loops 
(PTFE, 2-5 mL each) and subsequently pumped at equal flow 
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rates to unite at a T-piece (PEEK, 1.3 mm ID). The initial mixing 
resulted in an emulsion that then separated into individual 
droplets due to the biphasic nature of the solvent system. This 
stream was then directed through two tubular coiled reactors 
(PTFE, 10 mL each, ambient temperature, no active cooling) 
followed by a 75 psi back-pressure regulator prior to be collected 
into a round-bottom flask.  
Using this set-up allowed us to rapidly screen a selection of 
conditions and quickly confirm the viability of preparing the 
desired 5-chloro-1,2,4-thiadiazole building block 7 in a short 
residence time of only 5 minutes with yields up to 80%. 
Importantly the improved heat transfer offered by this flow 
approach meant that the reaction can be performed at ambient 
temperature without decomposition or run-away phenomena 
being observed. Although the desired reaction reaches 
completion in <5 minutes we elected to use a residence time of 
30 minutes in order to further ensure complete hydrolysis of any 
residual reagent 5 in addition to any of its hazardous by-products 
in the alkaline aqueous co-solvent. This is very selective as the 
desired product 7 resides preferentially in the organic phase 
which minimizes its hydrolysis to the corresponding 5-hydroxy 
derivative (8). This is more difficult to achieve in a batch process 
showcasing another benefit of this flow process. Encouraged by 
these results we decided to test the scale up of 7 by processing a 
20-fold amount of starting materials in an analogous fashion (20 
mmol scale). Pleasingly this directly translated into an efficient 
access to multi-gram quantities of the desired 5-chloro-1,2,4-
thiadiazole 7 which was isolated in pure form after aqueous 
extraction and filtration over a short plug of silica with hexanes 
as the eluent yielding 3.25 g of 7 (83%).  
With sufficient quantities of compound 7 in hand we 
proceeded to study its functionalization via reaction with 
different nucleophiles in a simple parallel batch process. We 
therefore dissolved aliquots of 7 in CH2Cl2 (1.0 mmol, 2.5 M) 
and added the desired nucleophile (1.1 equiv.) and triethylamine 
as base (1.1 equiv.). The reactions were stirred at 25 °C until 
complete conversion of 7 was indicated by tlc (typically 2-8 h) 
followed by evaporation and purification by silica gel 
chromatography. Pleasingly, this approach allowed us to quickly 
generate a small selection of reaction products based on various 
nitrogen nucleophiles including aliphatic as well as variable 
cyclic amine species (Scheme 2).  
 
Scheme 2: Functionalization of 7 with amine nucleophiles. 
Furthermore, we established that substituted thioimidazoles 
obtained via a Marckwald multicomponent reaction
28
 are equally 
competent nucleophiles analogously delivering interesting sulfide 
linked architectures in good yield (Figure 2). Finally, we found 
that 5-phenoxy substituted 1,2,4-thiadiazoles can be generated by 
treating a solution of 7 (0.5 M, THF) at room temperature with 
phenols in the presence of polymer-substituted BEMP as base 
leading to the clean and high-yielding formation of the desired 
adduct 21 (Figure 2). 
 
 
 
 
 
 
 
 
Figure 2: Structures of sulfur- and oxygen-linked products 18-
21. 
The connectivity of selected reaction products (13 and 20) was 
confirmed by single crystal X-ray diffraction experiments (Figure 
3). This also revealed an interesting π-stacking phenomenon 
between the thiadiazole ring and a nearby aryl moiety in the case 
of sulfide linked entities (e.g. 20). 
             
                                             
Figure 3: X-ray crystal structures of 13 (left) and 20 (right). 
In an extension of our studies we decided to investigate the 
formation of 5-chloro-1,2,4-thiadiazole building blocks that 
would enable functionalization in a bidirectional sense. To this 
end we opted to incorporate bromo-substituents located at 
different positions of the phenyl moiety enabling future 
diversification by means of metal mediated amination or cross-
coupling reactions (Figure 4).  
 
Figure 4: Key scaffold for bidirectional diversification. 
The required bromophenylamidine substrates (22-24) were 
prepared by reacting ortho-, meta- and para-bromobenzonitrile 
(0.5 M, THF) with a solution of NaHMDS (1.5 M, 1.2 equiv., 
THF, 1 h, rt) rendering after treatment with aqueous hydrochloric 
acid the desired bromophenylamidine HCl-salts 22-24 (see 
experimental section for full details). Having gained a quick 
access to these substrates we applied them towards the flow-
synthesis of the corresponding thiadiazole derivatives (Scheme 
3). In order to avoid any potential solubility issues we modified 
the initial set-up by first mixing trichloromethane 
sulfenylchloride (5, stream 1, 0.45 M, EtOAc) with the 
bromophenylamidine HCl-salt (22-24, stream 2, 0.4 M, H2O) 
prior to adding a stream containing NaOH (stream 3, 1.5 M, 
H2O). The resulting biphasic reaction mixture was then again 
directed through two flow coils maintained at ambient 
temperature (residence time 30 minutes) before being collected 
and purified by aqueous work-up and silica column 
chromatography. Pleasingly this approach enabled the rapid and 
high yielding generation of three regioisomeric building blocks 
(25-27) that can be exploited towards expanded thiadiazole 
libraries. 
 
Scheme 4: Flow synthesis of thiadiazoles 25-27. 
 
3. Conclusion 
In conclusion we have developed a flow process for 
converting benzamidine HCl-salts into valuable 1,2,4-thiadiazole 
derivatives based on safely utilizing trichloromethane 
sulfenylchloride as a versatile reagent. Exploiting the 5-chloro 
substituent we subsequently demonstrated the simple generation 
of a small set of 1,2,4-thiadiazole derivatives bearing different 
nitrogen-, sulfur- or oxygen-nucleophiles by means of efficient 
SNAr reactions. Finally, we extended our methodology to also 
access reaction products containing a bromophenyl moiety that 
together with the 5-chloro functionality allows for orthogonal and 
regiospecific diversification of the 1,2,4-thiadiazole system. 
 
4. Experimental protocols 
4.1 General methods and materials 
Unless otherwise stated, all solvents, substrates and reagents 
were used as purchased without further purification.  
1
H-NMR spectra were recorded on 400 MHz instruments and 
are reported relative to residual solvent: CHCl3 (δ 7.26 ppm) or 
DMSO (δ 2.50 ppm). 
13
C-NMR spectra were recorded on the 
same instrument and are reported relative to CHCl3 (δ 77.16 
ppm) or DMSO (δ 39.52 ppm). Data for 
1
H-NMR are reported as 
follows: chemical shift (δ/ ppm) (integration, multiplicity, 
coupling constant (Hz)). Multiplicities are reported as follows: s 
= singlet, d = doublet, t = triplet, q = quartet, p = pentet, m = 
multiplet, br. s = broad singlet, app = apparent. Data for 
13
C-
NMR are reported in terms of chemical shift (δ/ ppm) and 
multiplicity (C, CH, CH2 or CH3). DEPT-135, COSY, HSQC, 
HMBC and NOESY experiments were used in the structural 
assignment. IR spectra were recorded neat (ATR sampling) with 
the intensities of the characteristic signals being reported as weak 
(w, <20% of tallest signal), medium (m, 21-70% of tallest signal) 
or strong (s, >71% of tallest signal). Low and high resolution 
mass spectrometry was performed using the indicated techniques 
on instruments equipped with Acquity UPLC and a lock-mass 
electrospray ion source. Melting points were recorded on an 
automated melting point system with a heating rate of 1 °C/min 
and are uncorrected.  
4.2 Synthetic procedures 
In order to synthesise 5-chloro-1,2,4-thiadiazole 7 stock 
solutions of 5 (0.45 M in EtOAc) and hydrated benzamidine 
hydrochloride salt (6, 0.4 M in 1.5 M aqueous NaOH) were 
prepared  and injected into the sample loops (2-5 mL) of a 
Vapourtec R-series flow system. Both streams were pumped at 
equal flow rates (0.33 mL/min) and directed into two successive 
tubular flow reactors (10 mL each, rt) after being combined at a 
T-piece. Upon exiting the second flow reactor the combined 
reaction stream passed a back-pressure regulator (75 psi) before 
being collected into a flask. After aqueous extraction (3 x 10 mL 
water) the organic layer was dried over anhydrous sodium 
sulfate, filtered and evaporated to dryness. The organic residue 
was further purified by silica column chromatography using 
EtOAc/hexanes (5/95 to 10/90) as eluent yielding the desired 
thiadiazole 7 after evaporation of all volatiles as a yellow oil. 
Small amounts of hydrolysis product 8 were isolated as white 
solid. 
4.2.1 5-Chloro-3-phenyl-1,2,4-thiadiazole (7). 
At 1 mmol scale: Yellow oil; yield: 80%. 
1
H-NMR (400 MHz, 
CDCl3): δ 8.22-8.28 (m, 2H), 7.45-7.70 (m, 3H). 
13
C-NMR (101 
MHz, CDCl3): δ 172.9 (C), 172.1 (C), 131.9 (C), 130.9 (CH), 
128.8 (2CH), 128.1 (2CH). IR (neat, ν/cm
-1
): 1471 (s), 1439 (s), 
1319 (m), 1273 (s), 1112 (m), 1057 (s), 781 (m), 706 (s), 688 (s), 
650 (m). HRMS (ES-TOF
+
) calculated for C8H6N2ClS 196.9940, 
found 196.9941.   
4.2.1 3-Phenyl-1,2,4-thiadiazole-5-ol (8). 
Isolated as a by-product. White solid; melting range: 204.6-
207.0 °C; yield: 10-20%. 
1
H-NMR (400 MHz, d6-DMSO): δ 
13.41 (br s, 1H), 7.90-7.99 (m, 2H), 7.49-7.55 (m, 3H). 
13
C-NMR 
(101 MHz, d6-DMSO): δ 180.0 (C), 155.1 (C), 131.8 (CH), 129.4 
(2CH), 129.0 (C), 127.0 (2CH). IR (neat, ν/cm
-1
): 2800-3200 
(br), 1642 (s), 1542 (m), 1504 (m), 1463 (m), 1434 (m), 1175 
(m), 919 (m), 778 (s), 733 (m), 689 (s), 593 (s), 466 (m). HRMS 
(ES-TOF
+
) calculated for C8H7N2OS 179.0279, found 179.0282. 
For derivatizing 5-chloro-3-phenyl-1,2,4-thiadiazole (7) with 
different nucleophiles a solution of 7 (1.0 equiv., 2.5 M, DCM) 
was prepared. The desired nucleophile (1.1 equiv.) and 
triethylamine (1.1 equiv.) were added to this solution. The 
resulting reaction mixture was stirred at 25 °C until complete 
consumption of the substrates was observed by tlc (2-8 h). After 
aqueous extraction (3 x 10 mL water) the organic layer was dried 
over anhydrous sodium sulfate, filtered and evaporated to 
dryness furnishing the desired product which was furthermore 
purified by silica column chromatography (EtOAc/hexanes 10/90 
to 30/70). 
4.2.2 N-(2-(Cyclohex-1-en-1-yl)ethyl)-3-phenyl-1,2,4-
thiadiazole-5-amine (9). 
White solid; melting range: 138.0-140.5 °C; yield: 86%. 
1
H-
NMR (400 MHz, CDCl3): δ 8.13-8.18 (m, 2H), 7.39-7.45 (m, 
3H), 6.32 (br s, 1H), 5.49 (br s, 1H), 3.31 (app q, J = 6.6 Hz, 2H), 
2.28 (app t, J = 6.6 Hz, 2H), 1.95-2.05 (m, 2H), 1.85-1.93 (m, 
2H), 1.56-1.62 (m, 2H), 1.48-1.55 (m, 2H). 
13
C-NMR (101 MHz, 
CDCl3): δ 184.5 (C), 170.0 (C), 133.5 (C), 133.3 (C), 129.9 
(CH), 128.5 (2CH), 127.9 (2CH), 124.8 (CH), 44.3 (CH2), 37.2 
(CH2), 27.7 (CH2), 25.2 (CH2), 22.7 (CH2), 22.2 (CH2). IR (neat, 
ν/cm
-1
): 3235 (m), 2923 (m), 1575 (s), 1459 (m), 1426 (m), 1349 
(s), 1299 (m), 1071 (m), 1017 (m), 779 (m), 703 (s), 576 (m). 
HRMS (ES-TOF
+
) calculated for C16H20N3S 286.1378, found 
286.1371.   
4.2.3 N-Benzyl-3-phenyl-1,2,4-thiadiazol-5-amine (10). 
White solid; melting range: 101.6-103.8 °C; yield: 82%. 
1
H-
NMR (400 MHz, CDCl3): δ 8.13-8.18 (m, 2H), 7.37-7.43 (m, 
3H), 7.30-7.36 (m, 5H), 6.76 (br s, 1H), 4.49 (d, J = 5.6 Hz, 2H). 
13
C-NMR (101 MHz, CDCl3): δ 184.5 (C), 169.9 (C), 136.2 (C), 
133.2 (C), 129.9 (CH), 128.9 (2CH), 128.5 (2CH), 128.2 (CH), 
127.9 (2CH), 127.7 (2CH), 50.5 (CH2). IR (neat, ν/cm
-1
): 3215 
(m), 3029 (w), 1739 (w), 1559 (s), 1467 (m), 1430 (m), 1345 (s), 
1217 (w), 1027 (w), 707 (s). HRMS (ES-TOF
+
) calculated for 
C15H14N3S 268.0908, found 268.0900.   
4.2.4 N-(2-Morpholinoethyl)-3-phenyl-1,2,4-thiadiazol-5-
amine (11). 
Colourless oil; yield: 76%. 
1
H-NMR (400 MHz, CDCl3): δ 
8.13-8.19 (m, 2H), 7.35-7.45 (m, 3H), 6.40 (br s, 1H), 3.70-3.77 
(m, 4H), 3.35-3.42 (m, 2H), 2.66-2.71 (m, 2H), 2.47-2.55 (m, 
4H). 
13
C-NMR (101 MHz, CDCl3): δ 184 (C), 170.2 (C), 133.3 
(C), 129.9 (CH), 128.5 (2CH), 127.9 (2CH), 66.9 (2CH2), 56.2 
(CH2), 53.2 (2CH2), 42.1 (CH2). IR (neat, ν/cm
-1
): 3269 (w), 2970 
(w), 1739 (s), 1561 (s), 1430 (m), 1349 (s), 1217 (s), 1117 (m), 
707 (s). HRMS (ES-TOF
+
) calculated for C14H19N4SO 291.1280, 
found 291.1279.   
4.2.5 (Rac)-Methyl 4-methyl-2-((3-phenyl-1,2,4-thiadiazol-5-
yl)amino)pentanoate (12). 
Yellow oil; yield: 73%. 
1
H-NMR (400 MHz, CDCl3): δ 8.12-
8.19 (m, 2H), 7.37-7.44 (m, 3H), 6.15 (d, J = 8.4 Hz, 1H), 4.45-
4.50 (m, 1H), 3.79 (s, 3H), 1.70-1.82 (m, 3H), 0.99 (t, J = 6.1 Hz, 
6H). 
13
C-NMR (101 MHz, CDCl3): δ 183.0 (C), 173.0 (C), 169.8 
(C), 133.1 (C), 129.9 (CH), 128.4 (2CH), 128.0 (2CH), 57.2 
(CH), 52.6 (CH3), 41.8 (CH2), 24.8 (CH), 22.7 (CH3), 22.0 (CH3). 
IR (neat, ν/cm
-1
): 3297 (w), 2957 (m), 1744 (s), 1551 (s), 1469 
(s), 1433 (s), 1345 (s), 1273 (m), 1205 (s), 1171 (m), 708 (s). 
HRMS (ES-TOF
+
) calculated for C15H20N3O2S 306.1276, found 
306.1276.   
4.2.6 5-(Azetidin-1-yl)-3-phenyl-1,2,4-thiadiazole (13). 
Colourless solid; melting range: 103.5-104.3 °C; yield: 84%. 
1
H-
NMR (400 MHz, CDCl3): δ 8.15-8.25 (m, 2H), 7.37-7.45 (m, 
3H), 4.18 (app t, J = 7.6 Hz, 4 H), 2.50 (app p, J = 7.6 Hz, 2H). 
13
C-NMR (101 MHz, CDCl3): δ 184.3 (C), 170.4 (C), 133.4 (C), 
129.8 (CH), 128.4 (2CH), 128.1 (2CH), 53.7 (2CH2), 17.8 (CH2). 
IR (neat, ν/cm
-1
): 3045 (w), 2949 (w), 2870 (w), 1745 (w), 1575 
(s), 1463 (s), 1432 (s), 1352 (s), 1283 (m), 702 (s). HRMS (ES-
TOF
+
) calculated for C11H12N3S 218.0752, found 218.0757. 
Crystal data for 13: C11H11N3S, M = 217.29, triclinic, space 
group P -1, a = 7.3473(4), b = 12.0606(7), c = 12.6147(7) Å, α = 
71.093(5),  = 75.062(5), γ = 81.387(5)°, U = 1019.08(11) Å
3
, 
F(000) = 456, Z = 4, Dc = 1.416 mg m
-3
,  = 0.284 mm
-1
 (Mo-
K,  = 0.71073 Å), T = 120(1)K. 15847 reflections were 
collected on an Agilent Xcalibur diffractometer (Sapphire-3 CCD 
detector, fine-focus tube, graphite monochromator) yielding 5660 
unique data (Rmerg = 0.034). The structure was solved by direct 
method and refined by full-matrix least squares on F
2
 for all data 
using SHELXTL and OLEX2 software.
29,30
 All non-hydrogen 
atoms were refined with anisotropic displacement parameters, H-
atoms were placed into calculated positions and refined in riding 
mode. Final wR2(F
2
) = 0.1035 for all data 271 refined 
parameters), conventional R1 (F) = 0.0383 for 4524 reflections 
with I  2, GOF = 1.021. Crystallographic data for the structure 
have been deposited with the Cambridge Crystallographic Data 
Centre as supplementary publication CCDC-1519611. 
 
 4.2.7 (Rac)-(2R,4R,5S)-2-Ethyl 4-methyl 4-methyl-1-(3-
phenyl-1,2,4-thiadiazol-5-yl)-5-(thiophen-2yl)pyrrolidine-2,4-
dicarboxylate (14). 
Yellow oil; yield: 79%. 
1
H-NMR (400 MHz, CDCl3): δ 8.15-8.10 
(m, 2H), 7.42-7.34 (m, 4H), 7.30 (dd, J = 5.0, 1.2 Hz, 1H), 6.98 
(dd, J = 5.1, 3.6 Hz, 1H), 4.84 (s, 1H), 4.74 (dd, J = 10.2, 6.9 Hz, 
1H), 4.42-4.28 (m, 2H), 3.45 (s, 3H), 3.08 (dd, J = 13.1, 10.3 Hz, 
1H), 2.35 (dd, J = 13.1, 7.0 Hz, 1H), 1.56 (s, 3H), 1.35 (t, J = 7.1 
Hz, 3H). 
13
C-NMR (101 MHz, CDCl3): δ 181.0 (C), 171.9 (C), 
170.8 (C), 169.3 (C), 138.6 (C), 133.2 (C), 128.8 (CH), 128.4 
(2CH), 128.1 (CH), 128.0 (2CH), 126.9 (CH), 126.6 (CH), 71.2 
(CH), 62.3 (CH), 61.8 (CH2), 55.2 (C), 52.2 (CH3), 36.8 (CH2), 
23.4 (CH3), 14.3 (CH3). IR (neat, ν/cm
-1
): 2971 (w), 1739 (s), 
1537 (m), 1465 (m), 1434 (m), 1351 (s), 1230 (m), 1204 (m), 
1131 (m), 708 (s). HRMS (ES-TOF
+
) calculated for 
C22H24N3O4S2 458.1208, found 458.1208.   
4.2.8 5-(4-Methylpiperazin-1-yl)-3-phenyl-1,2,4-thiadiazole 
(15). 
Off-white solid; melting range: 222.1-225.0 °C; yield: 87%. 
1
H-NMR (400 MHz, CDCl3): δ 8.17-8.21 (m, 2H), 7.38-7.43 (m, 
3H), 3.62 (app t, J = 5.2 Hz, 4H), 2.54 (app t, J = 5.2 Hz, 4H), 
2.35 (s, 3H). 
13
C-NMR (101 MHz, CDCl3): δ 185.1 (C), 170.3 
(C), 133.5 (C), 129.8 (CH), 128.4 (2CH), 128.0 (2CH), 54.0 
(2CH2), 48.8 (2CH2), 46.2 (CH3). IR (neat, ν/cm
-1
): 1590 (w), 
1523 (s), 1504 (s), 1440 (m), 1368 (s), 1345 (s), 1131 (m), 1028 
(m), 743 (s), 702 (m), 683 (s), 644 (m). HRMS (ES-TOF
+
) 
calculated for C13H17N4S 261.1174, found 261.1186.   
4.2.9 3-Phenyl-5-(4-(pyrrolidin-1-yl)piperidin-1-yl)-1,2,4-
thiadiazole (16). 
Pale yellow oil; yield: 83%. 
1
H-NMR (400 MHz, CDCl3): δ 
8.15-8.20 (m, 2H), 7.35-7.43 (m, 3H), 3.96 (br d, J = 12.2 Hz, 
2H), 3.24 (ddd, J = 13.1, 11.3, 3.2 Hz, 2H), 2.55-2.70 (m, 4H), 
2.30-2.37 (m, 1H), 1.95-2.05 (m, 2H), 1.75-1.85 (m, 4H), 1.66-
1.74 (m, 2H). 
13
C-NMR (101 MHz, CDCl3): δ 184.9 (C), 170.3 
(C), 133.5 (C), 129.8 (CH), 128.4 (2CH), 128.0 (2CH), 60.7 
(CH), 51.3 (2CH2), 47.7 (2CH2), 30.2 (2CH2), 23.3 (2CH2). IR 
(neat, ν/cm
-1
): 2957 (m), 2787 (m), 1743 (w), 1556 (s), 1466 (s), 
1432 (s), 1356 (s), 1329 (m), 1294 (s), 1150 (m), 1117 (m), 933 
(w), 785 (w), 706 (s). HRMS (ES-TOF
+
) calculated for 
C17H23N4S 315.1643, found 315.1647. 
4.2.10 3-Phenyl-5-(4-phenylpiperazin-1-yl)-1,2,4-thiadiazole 
(17). 
Pale yellow solid; melting range: 135.0-135.6 °C. Yield: 85%. 
1
H-NMR (400 MHz, CDCl3): δ 8.20-8.27 (m, 2H), 7.40-7.47 (m, 
3H), 7.29-7.35 (m, 2H), 6.98 (d, J = 8.4 Hz, 2H), 6.96 (t, J = 8.4 
Hz, 1H), 3.74-3.79 (m, 4H), 3.32-3.36 (m, 4H). 
13
C-NMR (101 
MHz, CDCl3): δ 185.2 (C), 170.4 (C), 150.9 (C), 133.5 (C), 
129.9 (CH), 129.4 (2CH), 128.5 (2CH), 128.0 (2CH), 120.9 
(CH), 117.0 (2CH), 49.1 (2CH2), 48.8 (2CH2). IR (neat, ν/cm
-1
): 
2822 (w), 1599 (m), 1554 (s), 1502 (m), 1466 (s), 1433 (s), 1355 
(s), 1297 (m), 1230 (s), 1028 (m), 944 (m), 759 (m), 707 (s), 692 
(m). HRMS (ES-TOF
+
) calculated for C18H19N4S 323.1330, 
found 323.1331. 
4.2.11 (1-Methyl-2-((3-phenyl-1,2,4-thiadiazol-5-yl)thio)-
1H-imidazol-5-yl)methanol (18). 
Colourless oil; yield: 82%. 
1
H-NMR (400 MHz, CDCl3): δ 8.15-
8.19 (m, 2H), 7.39-7.45 (m, 3H), 7.10 (s, 1H), 4.62 (s, 2H), 4.35 
(br s, 1H), 3.72 (s, 3H). 
13
C-NMR (101 MHz, CDCl3): δ 185.1 
(C), 172.7 (C), 136.1 (C), 134.5 (C), 132.2 (C), 130.6 (CH), 
129.5 (CH), 128.7 (2CH), 128.2 (2CH), 54.4 (CH2), 31.8 (CH3). 
IR (neat, ν/cm
-1
): 3100-3500 (br), 2932 (w), 2871 (w), 1465 (s), 
1436 (s), 1319 (s), 1275 (s), 1112 (m), 1051 (m), 1025 (s), 953 
(w), 823 (w), 782 (w), 708 (s), 692 (m). HRMS (ES-TOF
+
) 
calculated for C13H13N4S2O 305.0531, found 305.0533.  
4.2.12 (1-Butyl-2-((3-phenyl-1,2,4-thiadiazol-5-yl)thio)-1H-
imidazol-5-yl)methanol (19). 
Colourless oil; yield: 76%. 
1
H-NMR (400 MHz, CDCl3): δ 8.18-
8.24 (m, 2H), 7.40-7.51 (m, 3H), 7.13 (s, 1H), 4.65 (s, 2H), 4.09 
(app t, J = 7.8 Hz, 2H), 3.63 (br s, 1H), 1.62-1.75 (m, 2H), 1.33 
(hex, J = 7.4 Hz, 2H), 0.89 (t, J = 7.4 Hz, 3H). 
13
C-NMR (101 
MHz, CDCl3): δ 185.1 (C), 172.4 (C), 135.3 (C), 134.9 (C), 
132.3 (C), 130.5 (CH), 129.8 (CH), 128.7 (2CH), 128.2 (2CH), 
54.6 (CH2), 45.4 (CH2), 33.1 (CH2), 20.0 (CH2), 13.6 (CH3). IR 
(neat, ν/cm
-1
): 3000-3500 (br), 2959 (m), 2929 (m), 2873 (w), 
1467 (s), 1436 (s), 1320 (s), 1276 (s), 1114 (w), 1055 (m), 1027 
(m), 786 (w), 709 (s). HRMS (ES-TOF
+
) calculated for 
C16H19N4S2O 347.1000, found 347.1006.  
4.2.13 (1-(2,6-Difluorobenzyl)-2-((3-phenyl-1,2,4-thiadiazol-
5-yl)thio)-1H-imidazol-5-yl)methanol (20). 
Colourless solid; melting range: 155.5-158.1 °C; yield: 70%. 
1
H-
NMR (400 MHz, d6-DMSO): δ 8.10-8.15 (m, 2H), 7.50-7.55 (m, 
3H), 7.32 (tt, J = 8.5, 6.6 Hz, 1H), 7.23 (s, 1H), 7.03 (app t, J = 
8.3 Hz, 2H), 5.47 (s, 2H), 5.37 (t, J = 5.4 Hz, 1H), 4.55 (d, J = 
5.4 Hz, 2H). 
13
C-NMR (101 MHz, d6-DMSO): δ 185.4 (C), 171.4 
(C), 161.1 (2CF, dd, J = 249, 8 Hz), 137.7 (C), 134.4 (C), 132.2 
(C), 131.6 (CH, app t, J = 11 Hz), 131.2 (CH), 129.5 (2CH), 
129.1 (CH), 128.1 (2CH), 112.3 (2CH, m), 111.9 (C, app t, J = 
18 Hz), 53.8 (CH2), 37.7 (CH2). 
19
F-NMR (376 MHz, d6-DMSO): 
δ -114. IR (neat, ν/cm
-1
): 3000-3450 (br), 1628 (w), 1467 (s), 
1438 (s), 1424 (m), 1321 (m), 1277 (m), 1236 (m), 1049 (s), 
1026 (s), 987 (s), 902 (m), 868 (m), 789 (s), 702 (s). HRMS (ES-
TOF
+
) calculated for C19H15N4S2F2O 417.0655, found 417.0648. 
Crystal data for 20: C19H14N3S, M = 416.46, monoclinic, space 
group P 21/c, a = 37.5101(19), b = 7.0468(4), c = 14.0246(7) Å,  
= 100.807(2) °, U = 3641.3(3) Å
3
, F(000) = 1712, Z = 8, Dc = 
1.519 mg m
-3
,  = 0.331 mm
-1
 (Mo-K,  = 0.71073 Å), T = 
120(1)K. 50305 reflections were collected on an Bruker 
D8Venture diffractometer (Photon 100 CMOS detector, IμS-
microsource, focusing mirrrors) yielding 8358 unique data (Rmerg 
= 0.057). The structure was solved by direct method and refined 
as a 2-component twin by full-matrix least squares on F
2
 for all 
data using SHELXTL and OLEX2 software.
29,30
 H-atoms were 
placed into calculated positions and refined in riding mode. Final 
wR2(F
2
) = 0.1919 for all data (487 refined parameters), 
conventional R1 (F) = 0.0770 for 7497 reflections with I  2, 
GOF = 1.021. Crystallographic data for the structure have been 
deposited with the Cambridge Crystallographic Data Centre as 
supplementary publication CCDC-1519612. 
4.2.14 5-(4-Bromophenoxy)-3-phenyl-1,2,4-thiadiazole (21). 
Colourless solid; melting range: 82.3-84.9 °C; yield: 93%. 
1
H-
NMR (400 MHz, CDCl3): δ 8.13-8.22 (m, 2H), 7.60 (d, J = 8.9 
Hz, 2H), 7.40-7.48 (m, 3H), 7.30 (d, J = 8.9 Hz, 2H). 
13
C-NMR 
(101 MHz, CDCl3): δ 190.6 (C), 169.2 (C), 153.9 (C), 133.3 
(2CH), 132.6 (C), 130.6 (CH), 128.6 (2CH), 127.9 (2CH), 121.9 
(2CH), 120.1 (C). IR (neat, ν/cm
-1
): 3060 (w), 1510 (m), 1480 
(m), 1455 (m), 1334 (m), 1247 (m), 1189 (m), 1067 (m), 1009 
(m), 827 (m), 777 (m), 701 (s), 687 (s). HRMS (ES-TOF
+
) 
calculated for C14H10N2SBrO 332.9697, found 332.9696.  
 
For preparing bromobenzimidamide HCl-salts 22-24 the 
corresponding bromobenzonitriles (10 mmol, 1.0 equiv., 0.8 M, 
THF) were treated at ambient temperature with a solution of 
NaHMDS (1.5 M, THF, 1.2 equiv., 8 mL). The resulting reaction 
mixture was stirred at ambient temperature for 1 h before being 
quenched by addition of water (5 mL). After addition of aqueous 
hydrochloric acid (1 M, 15 mL) the aqueous layer was separated 
and evaporated to about 15% of its original volume resulting in 
crystallization of the desired HCl-salts 22-24 which were isolated 
in pure form as beige solids after filtration and drying at high 
vacuum. 
   4.2.15 2-Bromobenzimidamide hydrochloride (22). 
Beige solid; yield: 77%. 
1
H-NMR (400 MHz, d6-DMSO): δ 9.70 
(s, 2H), 9.64 (s, 2H), 7.79-7.85 (m, 1H), 7.54-7.65 (m, 3H). 
13
C-
NMR (101 MHz, d6-DMSO): δ 166.3 (C), 133.6 (CH), 133.5 
(CH), 132.2 (C), 130.0 (CH), 128.4 (CH), 120.1 (C). IR (neat, 
ν/cm
-1
): 3216 (br m), 3042 (br s), 1669 (s), 1595 (m), 1454 (m), 
1425 (m), 1040 (m), 727 (s), 677 (m). HRMS (ES-TOF
+
) 
calculated for C7H8N2Br 198.9871, found 198.9866.  
   4.2.16 3-Bromobenzimidamide hydrochloride (23). 
Beige solid; yield: 81%. 
1
H-NMR (400 MHz, d6-DMSO): δ 9.74 
(s, 2H), 9.50 (s, 2H), 8.12 (t, J = 1.8 Hz, 1H), 7.88-7.96 (m, 2H), 
7.56 (t, J = 8.1 Hz, 1H). 
13
C-NMR (101 MHz, d6-DMSO): δ 
165.0 (C), 136.9 (CH), 131.5 (CH), 131.3 (CH), 130.4 (C), 127.8 
(CH), 122.4 (C). IR (neat, ν/cm
-1
): 3239 (br s), 3027 (br s), 1673 
(s), 1519 (s), 1465 (s), 1080 (m), 884 (m), 796 (m), 710 (s), 659 
(s). HRMS (ES-TOF
+
) calculated for C7H8N2Br 198.9871, found 
198.9873.  
   4.2.17 4-Bromobenzimidamide hydrochloride (24). 
Beige solid; yield: 85%. 
1
H-NMR (400 MHz, d6-DMSO): δ 9.58 
(br s, 2H), 9.42 (br s, 2H), 7.85 (d, J = 8.0 Hz, 2H), 7.81 (d, J = 
8.0 Hz, 2H). 
13
C-NMR (101 MHz, d6-DMSO): δ 165.4 (C), 132.5 
(2CH), 130.7 (2CH), 128.1 (C), 127.7 (C). IR (neat, ν/cm
-1
): 
3322 (br s), 3135 9br s), 1669 (s), 1593 (s), 1480 (m), 1428 (m), 
1071 (m), 1009 (m), 841 (m), 776 (m), 695 (s), 623 (s). HRMS 
(ES-TOF
+
) calculated for C7H8N2Br 198.9871, found 198.9873. 
 
In order to synthesise 5-chloro-1,2,4-thiadiazoles 25-27 stock 
solutions of 5 (0.45 M in EtOAc) and the desired substrates 22-
24 (0.4 M in water) were prepared  and injected into the sample 
loops of a Vapourtec R-series flow system. Both streams (0.17 
mL/min each) were combined in a T-piece and subsequently 
mixed with a stream of aqueous NaOH (1.5 M, 0.33 mL/min) 
prior to entering two successive tubular flow reactors (10 mL 
each, rt). Upon exiting the second flow reactor the combined 
reaction stream passed a back-pressure regulator (75 psi) before 
being collected into a flask. After aqueous extraction (3 x 10 mL 
water) the organic layer was dried over anhydrous sodium 
sulfate, filtered and evaporated to dryness. The organic residue 
was further purified by silica column chromatography using 
EtOAc/hexanes (1/99 to 20/80) as eluent yielding the desired 
thiadiazoles (25-27) in pure form after evaporation of all 
volatiles.  
   4.2.18 3-(2-Bromophenyl)-5-chloro-1,2,4-thiadiazole (25). 
Yellow oil; yield: 82%. 
1
H-NMR (400 MHz, CDCl3): δ 7.85 (dd, 
J = 7.7, 1.8 Hz, 1H), 7.71 (dd, J = 8.0, 1.2 Hz, 1H), 7.41 (td, J = 
7.6, 1.3 Hz, 1H), 7.31 (ddd, J = 8.0, 7.4, 1.8 Hz, 1H). 
13
C-NMR 
(101 MHz, CDCl3): δ 172.8 (C), 171.2 (C), 134.2 (CH), 133.0 
(C), 132.3 (CH), 131.4 (CH), 127.4 (CH), 121.9 (C). IR (neat, 
ν/cm
-1
): 3058 (w), 1591 (w), 1468 (m), 1451 (s), 1292 (s), 1251 
(m), 1060 (s), 1026 (m), 899 (m), 766 (m), 734 (s). HRMS (TOF 
AP
+
) calculated for C8H5N2SBrCl 274.9045, found 274.9051.  
   4.2.19 3-(3-Bromophenyl)-5-chloro-1,2,4-thiadiazole (26). 
Yellow oil; yield: 79%. 
1
H-NMR (400 MHz, CDCl3): δ 8.38 (t, J 
= 1.8 Hz, 1H), 8.14 (dt, J = 7.8, 1.3 Hz, 1H), 7.59 (ddd, J = 7.9, 
2.0, 1.1 Hz, 1H), 7.33 (t, J = 7.9 Hz, 1H). 
13
C-NMR (101 MHz, 
CDCl3): δ 173.4 (C), 170.5 (C), 133.9 (CH), 133.6 (C), 131.1 
(CH), 130.3 (CH), 126.6 (CH), 122.9 (C). IR (neat, ν/cm
-1
): 3069 
(w), 1568 (w), 1469 (s), 1458 (s), 1427 (m), 1281 (s), 1057 (s), 
907 (m), 792 (m), 726 (s), 677 (s). HRMS (TOF AP
+
) calculated 
for C8H5N2SBrCl 274.9045, found 274.9073.  
   4.2.20 3-(4-Bromophenyl)-5-chloro-1,2,4-thiadiazole (27). 
Off-white amorphous solid; yield: 85%. 
1
H-NMR (400 MHz, 
CDCl3): δ 8.11 (d, J = 8.0 Hz, 2H), 7.61 (d, J = 8.0 Hz, 2H). 
13
C-
NMR (101 MHz, CDCl3): δ 173.3 (C), 171.1 (C), 132.1 (2CH), 
130.8 (C), 129.6 (2CH), 125.6 (C). IR (neat, ν/cm
-1
): 2924 (w), 
1715 (w), 1591 (m), 1461 (m), 1397 (m), 1305 (m), 1272 (m), 
1109 (m), 1058 (s), 1007 (m), 894 (m), 829 (s), 732 (s). HRMS 
(TOF AP
+
) calculated for C8H4N2SBrCl 273.8967, found 
273.8989.  
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